STOCK TITAN

D-Wave Receives Notice of Non-Compliance with NYSE Trading Share Price Listing Rule

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
Rhea-AI Summary
D-Wave Quantum Inc. received notice from the NYSE that it is not in compliance with the stock price requirement. The company intends to cure the deficiency and return to compliance within a six-month period.
Positive
  • D-Wave Quantum Inc. plans to regain compliance with the NYSE stock price requirement by maintaining a closing share price of at least $1.00 and an average closing share price of at least $1.00 over a 30 trading-day period.
Negative
  • None.

Intends to cure the deficiency and return to compliance with NYSE standard

PALO ALTO, Calif. & BURNABY, British Columbia--(BUSINESS WIRE)-- D-Wave Quantum Inc. (NYSE: QBTS) (the "Company"), a leader in quantum computing systems, software and the world’s first commercial supplier of quantum computers, today announced that it received notice from the New York Stock Exchange (the “NYSE”) on October 20, 2023 that it is not in compliance with Section 802.01C of the NYSE Listed Company Manual because, as of October 20, 2023, the average closing price of the Company’s common stock was less than $1.00 over a consecutive 30 trading-day period. The notice does not result in the immediate delisting of the Company’s common stock from the NYSE.

On October 24, 2023, the Company notified the NYSE that it intends to cure the stock price deficiency and to return to compliance with the NYSE continued listing standard. The Company can regain compliance at any time within the six-month period following receipt of the NYSE notice if on the last trading day of any calendar month during the cure period the Company has a closing share price of at least $1.00 and an average closing share price of at least $1.00 over the 30 trading-day period ending on the last trading day of that month.

Under the NYSE’s rules, if the Company determines that, if necessary, it will cure the stock price deficiency by taking an action that will require stockholder approval, it must so inform the NYSE in the above referenced notification and the price condition will be deemed cured if the price promptly exceeds $1.00 per share, and the price remains above that level for at least the following 30 trading days. The Company intends to consider available alternatives, including but not limited to a reverse stock split, that are subject to shareholder approval.

The Company’s common stock will continue to be listed and trade on the NYSE during this period, subject to the Company’s compliance with other NYSE continued listing standards.

About D-Wave Quantum Inc.

D-Wave is a leader in the development and delivery of quantum computing systems, software, and services, and is the world’s first commercial supplier of quantum computers—and the only company building both annealing quantum computers and gate-model quantum computers. Our mission is to unlock the power of quantum computing today to benefit business and society. We do this by delivering customer value with practical quantum applications for problems as diverse as logistics, artificial intelligence, materials sciences, drug discovery, scheduling, cybersecurity, fault detection, and financial modeling. D-Wave’s customers include Volkswagen, Mastercard, Deloitte, Davidson Technologies, ArcelorMittal, Siemens Healthineers, Unisys, NEC Corporation, Pattison Food Group Ltd., DENSO, Lockheed Martin, Forschungszentrum Jülich, University of Southern California, and Los Alamos National Laboratory.

Forward Looking Statements

Certain statements in this press release are forward-looking, as defined in the Private Securities Litigation Reform Act of 1995. These statements involve risks, uncertainties, and other factors that may cause actual results to differ materially from the information expressed or implied by these forward-looking statements and may not be indicative of future results. Forward-looking statements in this press release include, but are not limited to, statements regarding the Company’s intention to consider alternatives to cure the NYSE continued listing requirement deficiency. These forward-looking statements are subject to a number of risks and uncertainties, including, among others, various factors beyond management’s control, including general economic conditions and other risks; our ability to expand our customer base and the customer adoption of our solutions; risks within D-Wave’s industry, including anticipated trends, growth rates, and challenges for companies engaged in the business of quantum computing and the markets in which they operate; the outcome of any legal proceedings that may be instituted against us; risks related to the performance of our business and the timing of expected business or financial milestones; unanticipated technological or project development challenges, including with respect to the cost and/or timing thereof; the performance of our products; the effects of competition on our business; the risk that we will need to raise additional capital to execute our business plan, which may not be available on acceptable terms or at all; the risk that we may never achieve or sustain profitability; the risk that we are unable to secure or protect our intellectual property; volatility in the price of our securities; the risk that our securities will not maintain the listing on the NYSE; and the numerous other factors set forth in D-Wave’s Annual Report on Form 10-K for its fiscal year ended December 31, 2022 and other filings with the Securities and Exchange Commission. Undue reliance should not be placed on the forward-looking statements in this press release in making an investment decision, which are based on information available to us on the date hereof. We undertake no duty to update this information unless required by law.

Investor Contact:

Kevin Hunt

ir@dwavesys.com

Media Contact:

Alex Daigle

media@dwavesys.com

Source: D-Wave Quantum Inc.

FAQ

What notice did D-Wave Quantum Inc. receive from the NYSE?

D-Wave Quantum Inc. received notice from the NYSE that it is not in compliance with Section 802.01C of the NYSE Listed Company Manual.

How can D-Wave Quantum Inc. regain compliance with the NYSE stock price requirement?

D-Wave Quantum Inc. can regain compliance by maintaining a closing share price of at least $1.00 and an average closing share price of at least $1.00 over a 30 trading-day period.

What alternatives is D-Wave Quantum Inc. considering to cure the stock price deficiency?

D-Wave Quantum Inc. intends to consider available alternatives, including a reverse stock split, that are subject to shareholder approval.

D-Wave Quantum Inc.

NYSE:QBTS

QBTS Rankings

QBTS Latest News

QBTS Stock Data

1.64B
222.93M
1.79%
55.45%
7.99%
Computer Hardware
Services-computer Processing & Data Preparation
Link
United States of America
PALO ALTO